Immupharma Share Discussion Threads

[blackbear] 24/1/2018 17:13

Opened a new spreadbet this morning was surprised they are not closed for business on IMM after all the demand lately.

[ny boy] 24/1/2018 16:34

Didnt look like a proper h&s in the first place, IMHO. The right shoulder was far too high.

Investors returning for a bargain to join hands with the institutions @ 144p

Could look like a savvy entry level in a few months!

[compnews1] 24/1/2018 16:30

Having read what published this morning £10 million is from "Major new and existing institutional investors", "to make investment into potential indications emanating from the Company's P140 platform, in addition to lupus", "We look forward to providing our shareholders with further updates regarding the Lupuzor™ Phase III trial with key data still on track to be announced before the end of Q1 2018.". Note, the £10m is for work "in addition to lupus", note also they "BEFORE" the end of Q1 2018 (in the past they say by Q1 2018). They must be confident to say this and that institution don't just cough up money easily. The full transcript is in the link below

[waterloo01] 24/1/2018 16:27

Happy with the top up opportunity around the placing price. The original rumour was that they were raising £7m. Turns out II demand was such that they raised £10m. It also gives them a chance to highlight the P140 potential in other indications.

As such, as long as the results, which could be anytime from now to end March, show some efficiency, then it demonstrates the approach works and P140 becomes a platform and the value......

In short, as long as it doesn't bomb in the trial, and the raising today from II's suggests they were happy with the risk/reward at £1.44, even if they need to do a 2nd confirmation trial, P140 will be of significant interest to a lot of pharma, talks with whom, we were told today are ongoing!

[makingmillions] 24/1/2018 16:23

Could this close cancel off the head and shoulders.?

[jimmmy] 24/1/2018 16:10

level 2 now flipped over, looking very good imo

not seen the buy order side +ve for a long long time

[tenniselbow] 24/1/2018 16:00

N4P. Will run out of cash

[che7win] 24/1/2018 15:56

Well, Haven't spoken to IMM, but have spoken to IDP today.I'm satisfied IDP is an extreme bargain at the current price, one of lowest PEGs I've come across.

[top tips] 24/1/2018 15:55

Already had N4P and have moved some of the profits into IMM.

[qs99] 24/1/2018 15:52

totally off topic, but given my holding in IMM I'll take a liberty, but N4P is well and truly off and running as a tiddler to watch DYOR and IMO etc, won't say anymore but take a look if interested.

[volsung] 24/1/2018 15:48

Nice to see the top up shares from this morning in profit

[ny boy] 24/1/2018 15:47

Well suppported going forward with £10M of institutional funding, a floor @ 144p and plenty to look forward too.

[someuwin] 24/1/2018 15:45

Excellent volume today. Over 4 million shares traded already.

[lucicavi] 24/1/2018 15:39

I like CHertwins £45 target

Like it

A Lot

[lucicavi] 24/1/2018 15:38

An hour to go blue

[barriew] 24/1/2018 15:37

I think the derampers from the last 3 weeks who spent every waking hour here have now dissapeared , i think their job has been done, and too many people listened to them and dragged the price down into the 150's

I see today as positive, and all to do with striking a deal, showing they have the money to go it alone, they Have the money for a second trial if needed,
They are not going to take a bad deal, or one where they dont get the true value if a distribution deal, or a full sale.
They can push other parts of p140 into a ph 3 trial for other indications as they dont have any problems with side effects.

I think we should all sit and wait results, may even get a deal/ or informations on another indication going into ph 2/3 trials before results are released.
Only 2 months max to wait.

[poacher45] 24/1/2018 15:37

I think they have done it now firstly to get big institutions on board at a reasonable price and secondary he has plenty of money now so he can accelerate the tests on other chronic conditions. This will have the effect of making any big pharmaceutical company pay more because we can treat more chronic conditions.

[aussieb3] 24/1/2018 15:37

Yeah prob delayed buy , been a few them today , prob end up 150 finish

[lucicavi] 24/1/2018 15:35

A cheeky chappy just bought 100,000


NICE TO SEE YOU

TO SEE YOU



NICE

[lucicavi] 24/1/2018 15:35

Level 2 flying

[jimmmy] 24/1/2018 15:33

"Red thumb" take a hike, think you will find II figures have increased

[davew28] 24/1/2018 15:31

I reckon it was necessary to do the raise after the off label 6 month extension was offered, something they weren't expecting and unaccounted for. They couldn't really have turned down the requests from clinicians and patients. A small price to pay but not changed the final outcome.

[jimmmy] 24/1/2018 15:29

I like to see the nice round 10K and 5K trades, looking up

[ashehzi] 24/1/2018 15:25

"opodio24 Jan '18 - 14:35 - 11005 of 11012" you can buy 100K @149.19p

[abbotslynn] 24/1/2018 15:25

2 Very well reasoned posts

'The chairman has expressed substantial optimism in various interviews re the likely Phase 3 outcome. I find it more than surprising, therefore, that he raises money now rather than at the much higher share price level that would no doubt arise when his optimism is proven justified.'


'A lesson in listening to expert's on bb's who have no idea what company plans are until they are announced, but what puzzles me is why raise money for other indications before getting approval for Lupus, if the ceo is so confident he could have raised this money post approval at a much higher price.
Is he losing confidence as figures come in ?'